Correlation Between Neuropace and NuVasive

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and NuVasive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and NuVasive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and NuVasive, you can compare the effects of market volatilities on Neuropace and NuVasive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of NuVasive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and NuVasive.

Diversification Opportunities for Neuropace and NuVasive

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neuropace and NuVasive is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and NuVasive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NuVasive and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with NuVasive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NuVasive has no effect on the direction of Neuropace i.e., Neuropace and NuVasive go up and down completely randomly.

Pair Corralation between Neuropace and NuVasive

Given the investment horizon of 90 days Neuropace is expected to generate 3.13 times more return on investment than NuVasive. However, Neuropace is 3.13 times more volatile than NuVasive. It trades about 0.04 of its potential returns per unit of risk. NuVasive is currently generating about 0.01 per unit of risk. If you would invest  482.00  in Neuropace on July 28, 2024 and sell it today you would earn a total of  153.00  from holding Neuropace or generate 31.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy19.34%
ValuesDaily Returns

Neuropace  vs.  NuVasive

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in November 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
NuVasive 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NuVasive has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, NuVasive is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Neuropace and NuVasive Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and NuVasive

The main advantage of trading using opposite Neuropace and NuVasive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, NuVasive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuVasive will offset losses from the drop in NuVasive's long position.
The idea behind Neuropace and NuVasive pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios